Literature DB >> 10798210

Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus.

G L Moe1, A R Kristal, D S Levine, T L Vaughan, B J Reid.   

Abstract

This cross-sectional study reports associations between anthropometric measures, serum antioxidant concentrations, and present diet with measures of elevated cell proliferation in 51 patients with Barrett's esophagus. Cell proliferation was assessed as fractions of cells in the S and G2 phases, measured in biopsies of Barrett's tissue and analyzed by DNA content flow cytometry. Elevated proportions in the S and G2 phases predict progression to adenocarcinoma. The percentage of cells in the S phase was positively associated with waist-to-hip ratio (r = 0.33, p < 0.05) and negatively associated with serum and dietary selenium (r = -0.34 and -0.32, respectively, p < 0.05). The percentage of cells in the G2 phase was positively associated with weight change from age 25 (r = 0.39, p < 0.01) and negatively associated with dietary selenium (r = -0.31, p < 0.05). Selenium from breads and grains was negatively associated with the percentage of cells in the S phase (r = -0.41, p < 0.01) and the percentage of cells in the G2 phase (r = -0.41, p < 0.01). These results suggest that increasing weight gain in adulthood, increasing waist-to-hip ratio, and decreasing dietary selenium intake and serum levels increase the risk of progression of Barrett's esophagus to adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10798210     DOI: 10.1207/S15327914NC3601_2

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  13 in total

1.  Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

Authors:  Rebecca E Rudolph; Thomas L Vaughan; Alan R Kristal; Patricia L Blount; Douglas S Levine; Patricia C Galipeau; Laura J Prevo; Carissa A Sanchez; Peter S Rabinovitch; Brian J Reid
Journal:  J Natl Cancer Inst       Date:  2003-05-21       Impact factor: 13.506

2.  Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link?

Authors:  Douglas A Corley
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

3.  Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study.

Authors:  Linda M Dong; Alan R Kristal; Ulrike Peters; Jeannette M Schenk; Carissa A Sanchez; Peter S Rabinovitch; Patricia L Blount; Robert D Odze; Kamran Ayub; Brian J Reid; Thomas L Vaughan
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

Review 4.  Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.

Authors:  Ai Kubo; Douglas A Corley; Christopher D Jensen; Rubinder Kaur
Journal:  Nutr Res Rev       Date:  2010-07-13       Impact factor: 7.800

5.  Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature.

Authors:  Jessica L Petrick; Nan Li; Kathleen M McClain; Susan E Steck; Marilie D Gammon
Journal:  Curr Nutr Rep       Date:  2015-03-01

6.  A study to determine plasma antioxidant concentrations in patients with Barrett's oesophagus.

Authors:  D M Clements; D A Oleesky; S C Smith; H Wheatley; D A Hullin; T J Havard; D J Bowrey
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

7.  Vegetable and fruit intakes and risk of Barrett's esophagus in men and women.

Authors:  Olivia M Thompson; Shirley A A Beresford; Elizabeth A Kirk; Thomas L Vaughan
Journal:  Am J Clin Nutr       Date:  2009-01-14       Impact factor: 7.045

8.  Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus.

Authors:  Ai Kubo; Theodore R Levin; Gladys Block; Gregory J Rumore; Charles P Quesenberry; Patricia Buffler; Douglas A Corley
Journal:  Am J Gastroenterol       Date:  2008-07       Impact factor: 10.864

Review 9.  Predictors of progression in Barrett's esophagus: current knowledge and future directions.

Authors:  Ganapathy A Prasad; Ajay Bansal; Prateek Sharma; Kenneth K Wang
Journal:  Am J Gastroenterol       Date:  2010-01-26       Impact factor: 10.864

Review 10.  BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.

Authors:  Cathy Bennett; Paul Moayyedi; Douglas A Corley; John DeCaestecker; Yngve Falck-Ytter; Gary Falk; Nimish Vakil; Scott Sanders; Michael Vieth; John Inadomi; David Aldulaimi; Khek-Yu Ho; Robert Odze; Stephen J Meltzer; Eamonn Quigley; Stuart Gittens; Peter Watson; Giovanni Zaninotto; Prasad G Iyer; Leo Alexandre; Yeng Ang; James Callaghan; Rebecca Harrison; Rajvinder Singh; Pradeep Bhandari; Raf Bisschops; Bita Geramizadeh; Philip Kaye; Sheila Krishnadath; M Brian Fennerty; Hendrik Manner; Katie S Nason; Oliver Pech; Vani Konda; Krish Ragunath; Imdadur Rahman; Yvonne Romero; Richard Sampliner; Peter D Siersema; Jan Tack; Tony C K Tham; Nigel Trudgill; David S Weinberg; Jean Wang; Kenneth Wang; Jennie Y Y Wong; Stephen Attwood; Peter Malfertheiner; David MacDonald; Hugh Barr; Mark K Ferguson; Janusz Jankowski
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.